Cargando…
Economic burden of malaria on businesses in Ghana: a case for private sector investment in malaria control
BACKGROUND: Despite the significant gains made globally in reducing the burden of malaria, the disease remains a major public health challenge, especially in sub-Saharan Africa (SSA) including Ghana. There is a significant gap in financing malaria control globally. The private sector could become a...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5011924/ https://www.ncbi.nlm.nih.gov/pubmed/27599835 http://dx.doi.org/10.1186/s12936-016-1506-0 |
_version_ | 1782451922109726720 |
---|---|
author | Nonvignon, Justice Aryeetey, Genevieve Cecilia Malm, Keziah L. Agyemang, Samuel Agyei Aubyn, Vivian N. A. Peprah, Nana Yaw Bart-Plange, Constance N. Aikins, Moses |
author_facet | Nonvignon, Justice Aryeetey, Genevieve Cecilia Malm, Keziah L. Agyemang, Samuel Agyei Aubyn, Vivian N. A. Peprah, Nana Yaw Bart-Plange, Constance N. Aikins, Moses |
author_sort | Nonvignon, Justice |
collection | PubMed |
description | BACKGROUND: Despite the significant gains made globally in reducing the burden of malaria, the disease remains a major public health challenge, especially in sub-Saharan Africa (SSA) including Ghana. There is a significant gap in financing malaria control globally. The private sector could become a significant source of financing malaria control. To get the private sector to appreciate the need to invest in malaria control, it is important to provide evidence of the economic burden of malaria on businesses. The objective of this study, therefore, was to estimate the economic burden on malaria on businesses in Ghana, so as to stimulate the sector’s investment in malaria control. METHODS: Data covering 2012–2014 were collected from 62 businesses sampled from Greater Accra, Ashanti and Western Regions of Ghana, which have the highest concentration of businesses in the country. Data on the cost of businesses’ spending on treatment and prevention of malaria in staff and their dependants as well as staff absenteeism due to malaria and expenditure on other health-related activities were collected. Views of business leaders on the effect of malaria on their businesses were also compiled. The analysis was extrapolated to cover 5828 businesses across the country. RESULTS: The results show that businesses in Ghana lost about US$6.58 million to malaria in 2014, 90 % of which were direct costs. A total of 3913 workdays were lost due to malaria in firms in the study sample during the period 2012–2014. Businesses in the study sample spent an average of 0.5 % of the annual corporate returns on treatment of malaria in employees and their dependants, 0.3 % on malaria prevention, and 0.5 % on other health-related corporate social responsibilities. Again business leaders affirmed that malaria affects their businesses’ efficiency, employee attendance and productivity and expenses. Finally, about 93 % of business leaders expressed the need private sector investment in malaria control. CONCLUSIONS: The economic burden of malaria on businesses in Ghana cannot be underestimated. This, together with business leaders’ acknowledgement that it is important for private sector investment in malaria control, provides motivation for engagement of the private sector in financing malaria control activities. |
format | Online Article Text |
id | pubmed-5011924 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-50119242016-09-07 Economic burden of malaria on businesses in Ghana: a case for private sector investment in malaria control Nonvignon, Justice Aryeetey, Genevieve Cecilia Malm, Keziah L. Agyemang, Samuel Agyei Aubyn, Vivian N. A. Peprah, Nana Yaw Bart-Plange, Constance N. Aikins, Moses Malar J Research BACKGROUND: Despite the significant gains made globally in reducing the burden of malaria, the disease remains a major public health challenge, especially in sub-Saharan Africa (SSA) including Ghana. There is a significant gap in financing malaria control globally. The private sector could become a significant source of financing malaria control. To get the private sector to appreciate the need to invest in malaria control, it is important to provide evidence of the economic burden of malaria on businesses. The objective of this study, therefore, was to estimate the economic burden on malaria on businesses in Ghana, so as to stimulate the sector’s investment in malaria control. METHODS: Data covering 2012–2014 were collected from 62 businesses sampled from Greater Accra, Ashanti and Western Regions of Ghana, which have the highest concentration of businesses in the country. Data on the cost of businesses’ spending on treatment and prevention of malaria in staff and their dependants as well as staff absenteeism due to malaria and expenditure on other health-related activities were collected. Views of business leaders on the effect of malaria on their businesses were also compiled. The analysis was extrapolated to cover 5828 businesses across the country. RESULTS: The results show that businesses in Ghana lost about US$6.58 million to malaria in 2014, 90 % of which were direct costs. A total of 3913 workdays were lost due to malaria in firms in the study sample during the period 2012–2014. Businesses in the study sample spent an average of 0.5 % of the annual corporate returns on treatment of malaria in employees and their dependants, 0.3 % on malaria prevention, and 0.5 % on other health-related corporate social responsibilities. Again business leaders affirmed that malaria affects their businesses’ efficiency, employee attendance and productivity and expenses. Finally, about 93 % of business leaders expressed the need private sector investment in malaria control. CONCLUSIONS: The economic burden of malaria on businesses in Ghana cannot be underestimated. This, together with business leaders’ acknowledgement that it is important for private sector investment in malaria control, provides motivation for engagement of the private sector in financing malaria control activities. BioMed Central 2016-09-06 /pmc/articles/PMC5011924/ /pubmed/27599835 http://dx.doi.org/10.1186/s12936-016-1506-0 Text en © The Author(s) 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Nonvignon, Justice Aryeetey, Genevieve Cecilia Malm, Keziah L. Agyemang, Samuel Agyei Aubyn, Vivian N. A. Peprah, Nana Yaw Bart-Plange, Constance N. Aikins, Moses Economic burden of malaria on businesses in Ghana: a case for private sector investment in malaria control |
title | Economic burden of malaria on businesses in Ghana: a case for private sector investment in malaria control |
title_full | Economic burden of malaria on businesses in Ghana: a case for private sector investment in malaria control |
title_fullStr | Economic burden of malaria on businesses in Ghana: a case for private sector investment in malaria control |
title_full_unstemmed | Economic burden of malaria on businesses in Ghana: a case for private sector investment in malaria control |
title_short | Economic burden of malaria on businesses in Ghana: a case for private sector investment in malaria control |
title_sort | economic burden of malaria on businesses in ghana: a case for private sector investment in malaria control |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5011924/ https://www.ncbi.nlm.nih.gov/pubmed/27599835 http://dx.doi.org/10.1186/s12936-016-1506-0 |
work_keys_str_mv | AT nonvignonjustice economicburdenofmalariaonbusinessesinghanaacaseforprivatesectorinvestmentinmalariacontrol AT aryeeteygenevievececilia economicburdenofmalariaonbusinessesinghanaacaseforprivatesectorinvestmentinmalariacontrol AT malmkeziahl economicburdenofmalariaonbusinessesinghanaacaseforprivatesectorinvestmentinmalariacontrol AT agyemangsamuelagyei economicburdenofmalariaonbusinessesinghanaacaseforprivatesectorinvestmentinmalariacontrol AT aubynvivianna economicburdenofmalariaonbusinessesinghanaacaseforprivatesectorinvestmentinmalariacontrol AT peprahnanayaw economicburdenofmalariaonbusinessesinghanaacaseforprivatesectorinvestmentinmalariacontrol AT bartplangeconstancen economicburdenofmalariaonbusinessesinghanaacaseforprivatesectorinvestmentinmalariacontrol AT aikinsmoses economicburdenofmalariaonbusinessesinghanaacaseforprivatesectorinvestmentinmalariacontrol |